Medical illustration showing how plaque buildup and clot formation can restrict blood flow in arteries. Researchers have developed a luteolin-based nanomedicine that targets and stabilizes these ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

To enhance the therapeutic efficacy of ELA-11 and achieve targeted delivery to atherosclerotic plaques, a pH-responsive NP system, mPEG@ELA-11, was developed. This system was engineered to prolong ELA ...

Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few noticeable ...

Neratinib, an oral drug commonly used in the treatment of breast cancer, has shown potential in reducing vascular ...

For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and blood pressure control, reducing cholesterol using medications like aspirin and statins. Despite these ...

Please provide your email address to receive an email when new articles are posted on . Patients with lung cancer have a high prevalence of atherosclerosis. These patients may benefit from calcium ...

Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heart attacks and strokes, which are the most common causes of death worldwide. The complex mechanisms that lead ...

Preclinical data suggest neratinib dampens vascular inflammation and atherosclerosis by targeting ASK1 in endothelial cells, ...